AndrewMYeagerMD

Oncology • The Plains, VA

Hematologic Oncology

Professor of Medicine Emeritus, University of Arizona College of Medicine

Join to view full profile

Dr. Yeager is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Yeager's full profile

Already have an account?

Office
7385 Stoney Hill Ln
The Plains, VA 20198
Phone+1 520-343-4995

Education & Training

Johns Hopkins UniversityResidency, Pediatrics, 1980 - 1982
Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 1978 - 1980
Johns Hopkins UniversityResidency, Pediatrics, 1975 - 1978
Johns Hopkins University School of MedicineClass of 1975

Certifications & Licensure

AZ State Medical License 2004 - Present
VA State Medical License 2016 - 2026
PA State Medical License 2000 - 2006
GA State Medical License 1993 - 2001
MD State Medical License 1975 - 1995
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2004-2014
Top Doctors:Arizona State Castle Connolly, 2013
America's Top Doctors for Cancer Castle Connolly, 2005-2013

Clinical Trials

Peripheral Blood Stem Cell Transplantation (PBSCT)From Haploidentical Related Donors Start of enrollment: 2008 Feb 01
Completed
Phase 2
Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation Start of enrollment: 2006 Jan 23
Terminated
Phase 2
Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia Start of enrollment: 2009 Sep 01
Active, not recruiting
Phase 2
Reduced Intensity Allogeneic PBSCT to Treat Hematologic Malignancies and Hematopoietic Failure States Start of enrollment: 2009 Sep 01
Completed
Phase 2
Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702) Start of enrollment: 2010 May 01
Completed
Phase 3
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
Recruiting
Join now to see all

Publications & Presentations

PubMed

93 citations
Overexpression of the MDM2 gene by childhood acute lymphoblastic leukemia cells expressing the wild-type p53 gene.
Muxiang Zhou, Andrew M. Yeager, Stephen D. Smith, Harry W. Findley
Blood. 1995-03-15
66 citations
Incidence and prognostic significance of MDM2 oncoprotein overexpression in relapsed childhood acute lymphoblastic leukemia
Muxiang Zhou, Lubing Gu, Thomas C. Abshire, Alan Homans, Amy L. Billett
Leukemia. 2000-01-01
233 citations
Long-Term Outcomes Among Older Patients Following Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Hematologic Malignancies
Mohamed L. Sorror, Brenda M. Sandmaier, Barry E. Storer, Georg Franke, Ginna G. Laport
JAMA. 2011-11-02

Press Mentions

Stem Cell Transplant Cements Arizona Men's Father-Son BondSeptember 10th, 2018
Intel Science Talent Contest Nurtures Spirit of InquiryFebruary 12th, 2016